Harvey Partners’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.8M Buy
320,000
+16,000
+5% +$2.1M 3.01% 10
2025
Q4
$36.2M Buy
+304,000
New +$34.6M 3.21% 12

Other funds holding NOVT

Harvey Partners's NOVT Position: Q1 2026 in Review

Harvey Partners increased its Novanta (NOVT) stake by 5.3% in Q1 2026, buying an estimated $2.1M and bringing the position to 320,000 shares worth $37.8M. The position accounts for 3.01% of the portfolio, ranked #10.

Harvey Partners first reported a position in NOVT in Q4 2025 and has held it in 2 quarters since. 329 funds tracked by Wall St. Rank hold NOVT as of Q1 2026.

  • Harvey Partners held 320,000 shares of Novanta worth $37.8M as of Q1 2026.
  • Harvey Partners bought 16,000 Novanta shares in Q1 2026, an estimated $2.1M.
  • Novanta made up 3.01% of Harvey Partners's portfolio in Q1 2026, its #10 holding.
  • Harvey Partners first reported a position in Novanta in Q4 2025 and has held it in 2 quarters since.
  • 329 funds tracked by Wall St. Rank held Novanta as of Q1 2026.

Based on Harvey Partners's 13F filing for Q1 2026, filed 15 May 2026.